Overview

The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease

Status:
Completed

Trial end date:
2019-10-04

Target enrollment:

Participant gender:

Summary

The RENEW Trial is a Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Reproxalap 0.25% Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease

Phase:

Phase 3

Details

Lead Sponsor:

Aldeyra Therapeutics, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions